Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Schedule of Net Loss Per Share

The following table reconciles net loss to net loss attributable to Heat Biologics, Inc.:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
Net loss	$	(2,504,178	)	$	(1,663,988	)	$	(9,053,987	)	$	(9,431,241	)
Net loss: Non-controlling interest		(203,371	)		(47,042	)		(344,328	)		(329,471	)
Net loss attributable to Heat Biologics, Inc.	$	(2,300,807	)	$	(1,616,946	)	$	(8,709,659	)	$	(9,101,770	)
Weighted-average number of common shares used in net loss per share attributable to Heat Biologics, Inc.—basic and diluted		35,786,606			19,420,026			32,695,360			15,371,267
Net loss per share attributable to Heat Biologics, Inc.—basic and diluted	$	(0.06	)	$	(0.08	)	$	(0.27	)	$	(0.59	)

Schedule of Potentially Dilutive Securities

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:

	For the Nine Months Ended September 30,
	2017		2016
Outstanding stock options		2,673,549		1,219,847
Outstanding restricted stock units		291,375		—
Outstanding common stock warrants		3,103,963		4,193,410